Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$25.32 - $51.45 $1.59 Million - $3.23 Million
-62,863 Reduced 88.24%
8,379 $307,000
Q3 2022

Nov 15, 2022

SELL
$46.5 - $79.14 $1.27 Million - $2.15 Million
-27,211 Reduced 27.64%
71,242 $3.36 Million
Q2 2022

Aug 15, 2022

SELL
$63.06 - $84.75 $7,188 - $9,661
-114 Reduced 0.12%
98,453 $7.06 Million
Q1 2022

May 12, 2022

SELL
$74.15 - $99.36 $14.9 Million - $20 Million
-200,873 Reduced 67.08%
98,567 $7.98 Million
Q4 2021

Feb 09, 2022

BUY
$86.01 - $102.89 $1.45 Million - $1.73 Million
16,834 Added 5.96%
299,440 $30.7 Million
Q3 2021

Nov 12, 2021

BUY
$84.7 - $96.31 $23.9 Million - $27.2 Million
282,606 New
282,606 $24.7 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Dana Investment Advisors, Inc. Portfolio

Follow Dana Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.